Linda M Randolph Selected Research

galsulfase

1/2021	Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy.
3/2014	Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda M Randolph Research Topics

Disease

2	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2021 - 03/2014
2	Fetofetal Transfusion (Twin Transfusion Syndrome) 04/2012 - 08/2010
1	Mucopolysaccharidoses 01/2021
1	Addison Disease (Addison's Disease) 11/2020
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 11/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	alpha-Thalassemia 05/2015
1	Anemia 05/2015
1	Fatal Infantile Lactic Acidosis 02/2011
1	Hirschsprung Disease (Hirschsprung's Disease) 09/2009

Drug/Important Bio-Agent (IBA)

2	galsulfase FDA Link 01/2021 - 03/2014
1	AndrogensIBA 11/2020
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	alpha-GlobinsIBA 05/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Mitochondrial DNA (mtDNA)IBA 02/2011
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 09/2009

Therapy/Procedure

3	Laser Therapy (Surgery, Laser) 01/2017 - 08/2010
2	Therapeutics 01/2017 - 03/2014
1	Enzyme Replacement Therapy 01/2021
1	Lasers (Laser) 08/2010